{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:07:08Z","timestamp":1779530828987,"version":"3.53.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"abstract":"<jats:p>Multiple factors including chronic infection with hepatitis B virus (HBV) are believed to increase the risk of HCC. Furthermore, recent studies on genetic mutations during HCC development have revealed potential genetic factors that may account for the development of the cancer, however, the roles of Visfatin polymorphisms and its relationship in HCC have not yet been demonstrated. The aim of current study was to investigate whether Visfatin gene polymorphisms could contribute to the susceptibility of HBV-related liver diseases in the Guangxi Chinese population. Two Visfatin single nucleotide polymorphisms, rs9034 and rs2505568, were genotyped using the single-base extension method in 140 chronic hepatitis B (CHB) patients, 143 hepatitis B virus (HBV)-related liver cirrhosis (LC) patients, 151 HBV-related hepatocellular carcinoma (HCC) patients, and 132 healthy subjects. Subjects carrying the rs2505568 AT genotype showed a significantly greater risk of CHB, LC, and HCC than those carrying the TT genotype. Similarly, carriers of the rs2505568 A allele had elevated risk for CHB, LC, and HCC, in comparison to carriers of the T allele. However, no significant differences in Visfatin rs9034 polymorphisms was observed between the healthy subjects and the patients. Our results suggested that Visfatin rs2505568 polymorphisms significantly associate with HBV-related CHB, LC, and HCC risk in the Guangxi Chinese population.<\/jats:p>","DOI":"10.1097\/md.0000000000045495","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:00:51Z","timestamp":1764972051000},"page":"e45495","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association between Visfatin gene rs9034 and rs2505568 polymorphisms with the risk of HBV-related hepatocellular carcinoma in a Chinese population: A case-control study"],"prefix":"10.1097","volume":"104","author":[{"given":"Zhi-Tong","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People\u2019s Hospital, Guigang, Guangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Fen","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People\u2019s Hospital, Guigang, Guangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People\u2019s Hospital, Guigang, Guangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wen","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People\u2019s Hospital, Guigang, Guangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Shan","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People\u2019s Hospital, Guigang, Guangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Nian","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People\u2019s Hospital, Guigang, Guangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People\u2019s Hospital, Guigang, Guangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5334-9797","authenticated-orcid":false,"given":"Jing-Yue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People\u2019s Hospital, Guigang, Guangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260523","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20260523","first-page":"115","article-title":"Cancer statistics in China, 2015.","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R3-20260523","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2008.10.040","article-title":"Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection.","volume":"286","author":"Chuang","year":"2009","journal-title":"Cancer Lett"},{"key":"R4-20260523","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/978-3-0348-0837-8_16","article-title":"The role of inflammation and liver cancer.","volume":"816","author":"Bishayee","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"R5-20260523","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1007\/s11010-021-04206-1","article-title":"Association of interleukin-18 genotypes (-607C > A) and (-137 G > C) with the hepatitis B virus disease progression to hepatocellular carcinoma.","volume":"476","author":"Ali","year":"2021","journal-title":"Mol Cell Biochem"},{"key":"R6-20260523","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jhep.2012.02.035","article-title":"Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis.","volume":"57","author":"Nahon","year":"2012","journal-title":"J Hepatol"},{"key":"R7-20260523","doi-asserted-by":"crossref","first-page":"7772","DOI":"10.1038\/s41598-021-87537-9","article-title":"Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression.","volume":"11","author":"Hoan","year":"2021","journal-title":"Sci Rep"},{"key":"R8-20260523","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.21672","article-title":"Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.","volume":"46","author":"Matsuzaki","year":"2007","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R9-20260523","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.clim.2009.10.007","article-title":"HCV-related hepatocellular carcinoma: from chronic inflammation to cancer.","volume":"134","author":"Castello","year":"2010","journal-title":"Clin Immunol"},{"key":"R10-20260523","doi-asserted-by":"crossref","first-page":"e23659","DOI":"10.1097\/MD.0000000000023659","article-title":"Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: an up-to-date meta-analysis.","volume":"99","author":"An","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R11-20260523","doi-asserted-by":"crossref","first-page":"104638","DOI":"10.1016\/j.meegid.2020.104638","article-title":"IL-17 and IL-21 polymorphisms in relation to HBV related hepatocellular carcinoma in Chinese Han population.","volume":"87","author":"Wu","year":"2021","journal-title":"Infect Genetics Evol"},{"key":"R12-20260523","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1186\/s12885-020-07606-6","article-title":"Association between five types of tumor necrosis factor-\u03b1 gene polymorphism and hepatocellular carcinoma risk: a meta-analysis.","volume":"20","author":"Wungu","year":"2020","journal-title":"BMC Cancer"},{"key":"R13-20260523","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","article-title":"Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.","volume":"178","author":"Moschen","year":"2007","journal-title":"J Immunol"},{"key":"R14-20260523","doi-asserted-by":"crossref","first-page":"23427","DOI":"10.18632\/oncotarget.15080","article-title":"Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma.","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"R15-20260523","doi-asserted-by":"crossref","first-page":"e0227459","DOI":"10.1371\/journal.pone.0227459","article-title":"Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC).","volume":"15","author":"Pazgan-Simon","year":"2020","journal-title":"PLoS One"},{"key":"R16-20260523","doi-asserted-by":"crossref","first-page":"22299","DOI":"10.3390\/ijms160922299","article-title":"Association of nicotinamide phosphoribosyltransferase (NAMPT) gene polymorphisms and of serum NAMPT levels with dilated cardiomyopathy in a Chinese Population.","volume":"16","author":"Dou","year":"2015","journal-title":"Int J Mol Sci"},{"key":"R17-20260523","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1349-7006.2010.01518.x","article-title":"Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer.","volume":"101","author":"Nakajima","year":"2010","journal-title":"Cancer Sci"},{"key":"R18-20260523","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cyto.2016.10.007","article-title":"Circulating visfatin level is associated with hepatocellular carcinoma in chronic hepatitis B or C virus infection.","volume":"90","author":"Tsai","year":"2017","journal-title":"Cytokine"},{"key":"R19-20260523","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1677\/jme.0.0260107","article-title":"Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes.","volume":"26","author":"Ognjanovic","year":"2001","journal-title":"J Mol Endocrinol"},{"key":"R20-20260523","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/oby.2006.247","article-title":"A visfatin promoter polymorphism is associated with low-grade inflammation and type 2 diabetes.","volume":"14","author":"Zhang","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"R21-20260523","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1007\/s13277-013-1527-z","article-title":"Genetic variants in NAMPT predict bladder cancer risk and prognosis in individuals from southwest Chinese Han group.","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol"},{"key":"R22-20260523","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12876-015-0282-6","article-title":"Genetic polymorphisms of NAMPT related with susceptibility to esophageal squamous cell carcinoma.","volume":"15","author":"Zhang","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"R23-20260523","doi-asserted-by":"crossref","first-page":"e1226","DOI":"10.1002\/mgg3.1226","article-title":"Impact of genetic variants of ABCB1, APOB, CAV1, and NAMPT on susceptibility to pancreatic ductal adenocarcinoma in Chinese patients.","volume":"8","author":"Li","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"R24-20260523","doi-asserted-by":"crossref","first-page":"104366","DOI":"10.1016\/j.meegid.2020.104366","article-title":"Association of LEPR gene polymorphisms with the risk of hepatitis B virus-related liver disease in Guangxi Chinese: a case-control study.","volume":"84","author":"Tang","year":"2020","journal-title":"Infect Genetics Evol"},{"key":"R25-20260523","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1086\/519979","article-title":"Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3\u2019 untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes.","volume":"81","author":"Sethupathy","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R26-20260523","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1159\/000485952","article-title":"Rs739837 polymorphism in MiR-885-3p binding site within 3\u2019-untranslated region of vitamin D receptor is associated with a decreased risk of pressure ulcers.","volume":"44","author":"Ji","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"R27-20260523","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1086\/323250","article-title":"Optimized group sequential study designs for tests of genetic linkage and association in complex diseases.","volume":"69","author":"K\u00f6nig","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R28-20260523","doi-asserted-by":"crossref","first-page":"e0158241","DOI":"10.1371\/journal.pone.0158241","article-title":"Association of hypoxia-inducible factor-2 alpha gene polymorphisms with the risk of hepatitis B virus-related liver disease in guangxi chinese: a case-control study.","volume":"11","author":"Huang","year":"2016","journal-title":"PLoS One"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:01:19Z","timestamp":1779530479000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":28,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045495","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2025-03-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}